Recently, Xin et al. utilized mice bearing neuroblastoma xenografts to demonstrate that GD2-CAR IL-15 NKT cells enhanced in vivo persistence, increased localization to tumor sites, and improved tumor control as compared with GD2-CAR NKT cells [52]. This evidence concerns the gene IL15 and neoplasm.